Results 121 to 130 of about 25,222 (258)

Rethinking natriuretic peptides: hypoxia and haemoconcentration in atrial fibrillation. [PDF]

Heart
Arjamaa O.
europepmc   +1 more source

Linking shox/shox2 deficiency with fgfr3 gain-of-function and natriuretic peptides. [PDF]

Front Endocrinol (Lausanne)
Hoffmann S, Diebold S, Roeth R, Löwen A, Mellein S, Just S, Rappold GA.   +6 more
europepmc   +1 more source

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

ESC Heart Failure, Volume 12, Issue 2, Page 1416-1426, April 2025.
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr, Stanislav Keranov, Paulina van Wickern, Holger Nef, Christian Hamm, Pascal Bauer, Christian Troidl, Samuel Sossalla, Sandra Voss, Christoph Liebetrau, Manuel J. Richter, Henning Gall, Werner Seeger, Ardeschir Ghofrani, Athiththan Yogeswaran, Khodr Tello   +15 more
wiley   +1 more source

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

ESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher, Kensuke Matsushita, Shinnosuke Kikuchi, Taraneh Tatarcheh, Benjamin Marchandot, Amandine Granier, Said Amissi, Antonin Trimaille, Laurence Jesel, Patrick Ohlmann, Kiyoshi Hibi, Valérie Schini‐Kerth, Olivier Morel   +12 more
wiley   +1 more source

Integrated use of natriuretic peptides and DASI for cardiac reserve evaluation in high-risk surgical patients: a narrative review. [PDF]

J Anesth Analg Crit Care
Senussi Testa T, Cuttone G, Damiani F, Ippati G, Zanza C, Misseri G, La Via L.   +6 more
europepmc   +1 more source

Developmental roles of natriuretic peptides and their receptors. [PDF]

Cells Dev, 2023
Juraver-Geslin H, Devotta A, Saint-Jeannet JP.   +2 more
europepmc   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Early neurological rehabilitation management in a stroke patient with persistently and extremely elevated natriuretic peptides: a case report. [PDF]

Front Med (Lausanne)
Han X, Huang Z.
europepmc   +1 more source

Machine learning to optimize the diagnostic performance of natriuretic peptides for acute heart failure across age groups. [PDF]

ESC Heart Fail
Perez Vicencio D, Doudesis D, Thurston AJF, Chenevier-Gobeaux C, Claessens YE, Lopez Ayala P, Belkin M, Wussler D, deFilippi C, Seliger S, Moe G, Fernando C, Bayes-Genis A, Pinto Y, Gaggin HK, Wiemer JC, Möckel M, Rutten JHW, Gargani L, Pugliese NR, Pemberton C, Ibrahim I, Gegenhuber A, Mueller T, Neumaier M, Behnes M, Akin I, Bombelli M, Grassi G, Nazerian P, Albano G, Bahrmann P, Richards AM, McMurray JJV, Mueller C, Januzzi JL, Mills NL, Lee KK.   +37 more
europepmc   +1 more source

Flexible wearable electronics for cardiovascular monitoring from surface signals to deep physiological insights

FlexMat, EarlyView.
This review organizes flexible wearable electronics for cardiovascular monitoring into four interconnected information layers: surface electrophysiology, hemodynamic sensing, vascular imaging, and biofluid biomarker analysis. This framework clarifies how electrical rhythm, vascular loading, structural and flow‐related features, and biochemical states ...
Qiao Chen, Hongwen Chen, Yuanyuan Li, Pingan Yang, Rui Li, Zhihao Zhou   +5 more
wiley   +1 more source